Evidence map›Paper›PMID 17943185›Full record

ArticleThe Journal of investigative dermatology2008

Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers.

Karin M Aberg, Mao-Qiang Man, Richard L Gallo, Tomas Ganz, Debra Crumrine, Barbara E Brown, Eung-Ho Choi, Dong-Kun Kim, Jens M Schröder, Kenneth R Feingold and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of investigative dermatology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed
16.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 219 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Secretory leukocyte protease inhibitor regulates nerve reflex-mediated skin barrier function in psoriasis.Journal of the European Academy of Dermatology and Venereology : JEADV · 2022
    Article
  14. Review
  15. Optimizing emollient therapy for skin barrier repair in atopic dermatitis.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2022
    Review
  16. Article
  17. Atopic Dermatitis: The Fate of the Fat.International journal of molecular sciences · 2022
    Review
  18. Review
  19. Article
  20. Keratinocytes: innate immune cells in atopic dermatitis.Clinical and experimental immunology · 2021
    Review

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Karin M AbergDermatology Service, Veterans Affairs Medical Center, University of California, San Francisco, California, USA. Karin_aberg@yahoo.com
Mao-Qiang Man
Richard L Gallo
Tomas Ganz
Debra Crumrine
Barbara E Brown
Eung-Ho Choi
Dong-Kun Kim
Jens M Schröder
Kenneth R Feingold
Peter M Elias
San Francisco VA Medical Center · USYonsei University · KRChristian-Albrechts-Universität zu Kiel · DEUCLA Health · USUniversity of California San Diego · US

Funding

RELATIONSHIP OF PERMEABILITY BARRIER FUNCTION AND EPIDERMAL CYTOKINE PRODUCTIONP01AR039448 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ELIAS, PETER M · 1988 to 2007
$11.8M
UCSF Dermatology Training GrantT32AR007175 · NIAMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Wilson Liao, Michael David Rosenblum · 1986 to 2026
$6.1M
NATURE OF THE MAMMALIAN CUTANEOUS PERMEABILITY BARRIERR01AR019098 · NIAMS · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI ELIAS, PETER M · 1986 to 2012
$4.2M
Risk Factors for Eczema Vaccinatum in Atopic DermatitisR01AI059311 · NIAID · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI HOLLERAN, WALTER M · 2005 to 2009
$1.9M
NIAID NIH HHS AI059311NIAID NIH HHS R01 AI059311NIAMS NIH HHS AR07175-28NIAMS NIH HHS AR19098NIAMS NIH HHS AR39448NIAMS NIH HHS P01 AR039448NIAMS NIH HHS R01 AR019098NIAMS NIH HHS T32 AR007175
6 · The paper itself

Abstract

Human epidermis elaborates two small cationic, highly hydrophobic antimicrobial peptides (AMP), beta-defensin 2 (hBD2), and the carboxypeptide cleavage product of human cathelicidin (hCAP18), LL-37, which are co-packaged along with lipids within epidermal lamellar bodies (LBs) before their secretion. Because of their colocalization, we hypothesized that AMP and barrier lipid production could be coregulated by altered permeability barrier requirements. mRNA and immunostainable protein levels for mBD3 and cathelin-related antimicrobial peptide (CRAMP) (murine homologues of hBD2 and LL-37, respectively) increase 1-8 hours after acute permeability barrier disruption and normalize by 24 hours, kinetics that mirror the lipid metabolic response to permeability barrier disruption. Artificial permeability barrier restoration, which inhibits the lipid-synthetic response leading to barrier recovery, blocks the increase in AMP mRNA/protein expression, further evidence that AMP expression is linked to permeability barrier function. Conversely, LB-derived AMPs are also important for permeability barrier homeostasis. Despite an apparent increase in mBD3 protein, CRAMP-/- mice delayed permeability barrier recovery, attributable to defective LB contents and abnormalities in the structure of the lamellar membranes that regulate permeability barrier function. These studies demonstrate that (1) the permeability and antimicrobial barriers are coordinately regulated by permeability barrier requirements and (2) CRAMP is required for permeability barrier homeostasis.

Indexed as

AnimalsAntimicrobial Cationic Peptidesbeta-DefensinsCathelicidinsEpidermisMiceMice, KnockoutMice, Mutant StrainsPermeabilityUp-RegulationAntimicrobial Cationic Peptidesbeta-DefensinsCathelicidinsDEFB103A protein, human

Identifiers

PMID17943185
PMCPMC2671223
OpenAlexW1999661190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.